To deal with this issue, we engineered a fibrosarcoma cell line by introducing a single point-mutation in GM-CSF sequence, generating a tumor model that stably secretes a GM-CSF mutant which is insensitive to RNS-induced PTM. The gene discussed is CSF2; the disease is fibrosarcoma.